BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hadjadj J, Frémond ML, Neven B. Emerging Place of JAK Inhibitors in the Treatment of Inborn Errors of Immunity. Front Immunol 2021;12:717388. [PMID: 34603291 DOI: 10.3389/fimmu.2021.717388] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Al-Hakim A, Mistry A, Savic S. Improving Diagnosis and Clinical Management of Acquired Systemic Autoinflammatory Diseases. J Inflamm Res 2022;15:5739-55. [PMID: 36238769 DOI: 10.2147/JIR.S343261] [Reference Citation Analysis]
2 Baris S, Abolhassani H, Massaad MJ, Al-nesf M, Chavoshzadeh Z, Keles S, Reisli I, Tahiat A, Shendi HM, Elaziz DA, Belaid B, Al Dhaheri F, Haskologlu S, Dogu F, Ben-mustapha I, Sobh A, Galal N, Meshaal S, Elhawary R, El-marsafy A, Alroqi FJ, Al-saud B, Al-ahmad M, Al Farsi T, Al Sukaiti N, Al-tamemi S, Mehawej C, Dbaibo G, Elghazali G, Kilic SS, Genel F, Kiykim A, Musabak U, Artac H, Guner SN, Boukari R, Djidjik R, Kechout N, Cagdas D, El-sayed ZA, Karakoc-aydiner E, Alzyoud R, Barbouche MR, Adeli M, Wakim RH, Reda SM, Ikinciogullari A, Ozen A, Bousfiha A, Al-mousa H, Rezaei N, Al-herz W, Geha RS. The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity. The Journal of Allergy and Clinical Immunology: In Practice 2022. [DOI: 10.1016/j.jaip.2022.10.003] [Reference Citation Analysis]
3 Hernandez JD, Hsieh EWY. A great disturbance in the force: IL-2 receptor defects disrupt immune homeostasis. Curr Opin Pediatr 2022. [PMID: 36165614 DOI: 10.1097/MOP.0000000000001181] [Reference Citation Analysis]
4 Costagliola G, Consolini R. Refractory immune thrombocytopenia: Lessons from immune dysregulation disorders. Front Med 2022;9. [DOI: 10.3389/fmed.2022.986260] [Reference Citation Analysis]
5 Bleesing J. Gain-of-function defects in toll-like receptor 8 shed light on the interface between immune system and bone marrow failure disorders. Front Immunol 2022;13:935321. [DOI: 10.3389/fimmu.2022.935321] [Reference Citation Analysis]
6 David C, Frémond ML. [When to consider type I interferonopathy in adulthood?]. Rev Med Interne 2022:S0248-8663(21)01114-0. [PMID: 35177256 DOI: 10.1016/j.revmed.2021.11.003] [Reference Citation Analysis]
7 David C, Frémond M. Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI). Cells 2022;11:318. [DOI: 10.3390/cells11030318] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
8 Forbes Satter LR. Monogenically driven therapies: the new first line. Blood 2022;139:162-3. [PMID: 35024814 DOI: 10.1182/blood.2021014323] [Reference Citation Analysis]